SCHEMBL2285047

SCHEMBL2285047

O=C(O)N1CC[C@@H](COc2ccc3ccccc3c2)C1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 3/20 0.52
SLC6A4 P31645 3/20 0.52
HTR3A P46098 1/20 0.52
KCNH2 Q12809 1/20 0.52
HPGD P15428 2/20 0.50
RAB9A P51151 2/20 0.50
NPC1 O15118 1/20 0.50
SLC6A3 Q01959 1/20 0.50
GPR183 P32249 1/20 0.48
PTPN7 P35236 1/20 0.48
GRIN2D O15399 1/20 0.47
GRIN3B O60391 1/20 0.47
GRIN1 Q05586 1/20 0.47
GRIN2A Q12879 1/20 0.47
GRIN2B Q13224 1/20 0.47
GRIN2C Q14957 1/20 0.47
GRIN3A Q8TCU5 1/20 0.47
HTT P42858 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.45
RBP4 P02753 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2227841 1.00 SLC6A2 (0.52) SLC6A2SLC6A4HTR3AKCNH2HPGD
SCHEMBL2227838 1.00 SLC6A2 (0.52) SLC6A2SLC6A4HTR3AKCNH2HPGD
SCHEMBL2358210 0.85 F2 (0.43) RAB9AGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL2355876 0.85 FFAR4 (0.42) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL7336107 0.84 CHEK2 (0.56) SLC6A2SLC6A4HTR3AKCNH2HPGD
SCHEMBL2287874 0.83 GPR119 (0.50) SLC6A2SLC6A4HTR3AKCNH2KDM4E
SCHEMBL2291580 0.83 GPR119 (0.50) SLC6A2SLC6A4HTR3AKCNH2KDM4E
SCHEMBL2287878 0.83 GPR119 (0.50) SLC6A2SLC6A4HTR3AKCNH2KDM4E
SCHEMBL20744482 0.82 CHRNB4 (0.52) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL20744410 0.82 CHRNB4 (0.52) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9000010-B2 Alkyl-heterocycle carbamate derivatives, their preparation and their therapeutic application SANOFI (FR) 2015-04-07 US claimed
EP-2526100-B1 ALKYL-HETEROCYCLE CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI SA (FR) 2013-12-04 EP claimed
US-20120295909-A1 ALKYL-HETEROCYCLE CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI (FR) 2012-11-22 US claimed
US-9000010-B2 Alkyl-heterocycle carbamate derivatives, their preparation and their therapeutic application SANOFI (FR) 2015-04-07 US disclosed
EP-2526100-B1 ALKYL-HETEROCYCLE CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI SA (FR) 2013-12-04 EP disclosed
US-20120295909-A1 ALKYL-HETEROCYCLE CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI (FR) 2012-11-22 US disclosed
WO-2011089550-A1 ALKYL-HETEROCYCLE CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI AVENTIS (FR) 2011-07-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120295909-A1 ALKYL-HETEROCYCLE CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION PRMT9, PRMT8, CBR1 SLC6A2 2876/4885SLC6A4 3841/4885HTR3A 2465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.